Spotlight:
The people behind ISTM
I am Dr Clare Hoskins, Lead of
the Nanopharmaceutics Research
Group. I was appointed as Lecturer in Pharmaceutics at Keele
University in 2011 with subsequent promotion to Senior Lecturer in 2016. I completed my PhD in
polymers for drug delivery at the
Robert Gordon University in Aberdeen. Following this I was appointed to a postdoctoral position
at the University of Dundee, to investigate the use of
metallic nanoparticles for application in nerve regeneration. My research interests at Keele concern the design
and fabrication of novel image guided drug delivery sys-
tems. I am a member of the Royal Society of Chemistry
(RSC); the United Kingdom & Ireland Controlled Release
Society (UKICRS); and the British Society for Nanomedicine and the Controlled Release Society (CRS). I sit as a
Committee Member of the CRS Preclinical Sciences and
Animal Health Committee and am currently the elected
Secretary of the RSC Chemical Nanosciences and Nanotechnology Network. I serve as an editorial board member for the Journal of Nanomedicine Research and recently was invited to Chair the 6th Global Experts Meeting on Nanotechnology and Nanomaterials conference.
Moving forward I am hoping to keep up this success and
help develop Keele University as a centre of excellence
for Nanopharmaceutics.
I am Dr Tony Curtis and I work
as a Senior Lecturer in Organic
and Medicinal Chemistry at Keele
University. I joined Keele in 1993
as Lecturer in Organic Chemistry
in the Department of Chemistry
and was one of the key figures in
setting up the School of Pharmacy within the Faculty of Medicine
and Health Sciences. I obtained
my PhD in anticancer drug synthesis from Manchester University and subsequently
was appointed to a postdoctoral position in Boston College, Massachussetts where I made simple enzyme
mimics. I carry out my research into synthetic chemistry,
drug discovery and delivery as part of the Keele
Nanopharmaceutics research group. Recently I was
awarded the Institute of Science and Technology in
Medicine Research Fellowship, which allowed me to
dedicate more time to research in the laboratory and to
help raise my profile in the field. I am a Fellow of the
Royal Society of Chemistry, and member of the American Chemical Society; Association for Pharmaceutical
Science; Controlled Release Society (CRS); United
Kingdom & Ireland Controlled Release Society
(UKICRS); British Society for Nanomedicine; and the
British Association for Cancer Research.
NANOPHARMACEUTICS
8